Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world patient data with the aim of designing robust clinical trials for proprietary Cannabis-based medicines that can achieve regulatory approval. Avextra announces its support of BELCANTO; a Phase 2 double-blind clinical trial initiated by 

​ Avextra is launching its Alliance for Evidence-based Cannabis Medicine: a platform focused on collaborating with healthcare professionals and researchers to generate real-world patient data with the aim of designing robust clinical trials for proprietary Cannabis-based medicines that can achieve regulatory approval. Avextra announces its support of BELCANTO; a Phase 2 double-blind clinical trial initiated by […] 

​Read More 

Cannabis Law Report